Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Terns Pharmaceuticals Inc shares valued at $11,498 were purchased by Jung Melita Sun on Nov 30 ’24. At $5.11 per share, Jung Melita Sun acquired 2,250 shares. The insider’s holdings grew to 2,250 shares worth approximately $10485.0 following the completion of this transaction.
Also, Burroughs Amy L. purchased 510 shares, netting a total of over 2,606 in proceeds. Following the buying of shares at $5.11 each, the insider now holds 19,609 shares.
Before that, Kuriakose Emil had sold 4,481 shares from its account. In a trade valued at $25,607, the Chief Medical Officer traded Terns Pharmaceuticals Inc shares for $5.71 each. Upon closing the transaction, the insider’s holdings decreased to 4,481 shares, worth approximately $0.25 million.
As published in their initiating research note from Oppenheimer on October 31, 2024, Terns Pharmaceuticals Inc [TERN] has been an Outperform and the price target has been revised to $82. Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 07, 2023, Jefferies has initiated its “Buy” rating for TERN. Earlier on May 31, 2023, ROTH MKM initiated its rating. Their recommendation was “a Buy” for TERN stock.
Analyzing TERN Stock Performance
During the last five days, there has been a surge of approximately 0.43%. Over the course of the year, Terns Pharmaceuticals Inc shares have dropped approximately -15.88%. Shares of the company reached a 52-week high of $5.95 on 01/06/25 and a 52-week low of $4.16 on 01/29/25. A 50-day SMA is recorded $5.53, while a 200-day SMA reached $6.88. Nevertheless, trading volume fell to 0.94 million shares from 1.6 million shares the previous day.
Support And Resistance Levels for Terns Pharmaceuticals Inc (TERN)
According to the 24-hour chart, there is a support level at 4.57, which, if violated, would cause prices to drop to 4.48. In the upper region, resistance lies at 4.74. The next price resistance is at 4.82. RSI (Relative Strength Index) is 43.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 22.66%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
